AIG
OMED

American International Group’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

American International Group’s Portfolio OMED Stock Details OMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-10,977
Closed -$101K – 3217
2017
Q1 		$101K Buy
10,977
+905
+9% +$7.95K ﹤0.01% 2589
2016
Q4 		$78K Sell
10,072
-27
-0.3% -$248 ﹤0.01% 2736
2016
Q3 		$115K Buy
10,099
+15
+0.1% +$175 ﹤0.01% 2519
2016
Q2 		$124K Buy
10,084
+39
+0.4% +$473 ﹤0.01% 2447
2016
Q1 		$101K Hold
10,045
– – ﹤0.01% 3423
2015
Q4 		$226K Sell
10,045
-18
-0.2% -$369 ﹤0.01% 2723
2015
Q3 		$167K Sell
10,063
-1,129
-10% -$22.6K ﹤0.01% 2996
2015
Q2 		$252K Buy
11,192
+1,445
+15% +$35.6K ﹤0.01% 2797
2015
Q1 		$251K Sell
9,747
-335
-3% -$8.5K ﹤0.01% 2759
2014
Q4 		$219K Sell
10,082
-850
-8% -$17.4K ﹤0.01% 2869
2014
Q3 		$207K Sell
10,932
-145
-1% -$2.91K ﹤0.01% 2934
2014
Q2 		$258K Buy
11,077
+4,527
+69% +$112K ﹤0.01% 2756
2014
Q1 		$220K Buy
6,550
+1,559
+31% +$52.5K ﹤0.01% 2759
2013
Q4 		$147K Buy
4,991
+3,821
+327% +$70K ﹤0.01% 3044
2013
Q3 		$17.9K Buy
+1,170
New +$21.7K ﹤0.01% 4105

Other funds holding OMED

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
IHM
Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

American International Group's OMED Position: Q2 2017 in Review

American International Group sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q2 2017, closing a stake of 10,977 shares — an estimated $101K sold.

American International Group first reported a position in OMED in Q3 2013 and held it in 15 quarters. The position peaked at $258K in Q2 2014. 68 funds tracked by Wall St. Rank hold OMED as of Q2 2017.

  • American International Group reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q2 2017 after selling out during the quarter.
  • American International Group sold 10,977 OncoMed Pharmaceuticals, Inc. shares in Q2 2017, an estimated $101K.
  • American International Group first reported a position in OncoMed Pharmaceuticals, Inc. in Q3 2013 and held it in 15 quarters.
  • American International Group's OncoMed Pharmaceuticals, Inc. position peaked at $258K in Q2 2014.
  • 68 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q2 2017.

Based on American International Group's 13F filing for Q2 2017, filed 11 Aug 2017.